Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1.48%
operating margin TTM
2.03%
revenue TTM
575.33 Million
revenue per share TTM
25.62$
valuation ratios | |
|---|---|
| pe ratio | -148.97 |
| peg ratio | -3.68 |
| price to book ratio | 3.76 |
| price to sales ratio | 2.49 |
| enterprise value multiple | 18.62 |
| price fair value | 3.76 |
profitability ratios | |
|---|---|
| gross profit margin | 57.95% |
| operating profit margin | 2.03% |
| pretax profit margin | -1.97% |
| net profit margin | -1.48% |
| return on assets | -0.82% |
| return on equity | -2.54% |
| return on capital employed | 1.37% |
liquidity ratios | |
|---|---|
| current ratio | 2.54 |
| quick ratio | 1.96 |
| cash ratio | 0.92 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 160.63 |
| operating cycle | 270.83 |
| days of payables outstanding | 63.37 |
| cash conversion cycle | 207.46 |
| receivables turnover | 3.31 |
| payables turnover | 5.76 |
| inventory turnover | 2.27 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.24 |
| debt equity ratio | 0.73 |
| long term debt to capitalization | 0.41 |
| total debt to capitalization | 0.42 |
| interest coverage | 0.62 |
| cash flow to debt ratio | 0.43 |
cash flow ratios | |
|---|---|
| free cash flow per share | 5.62 |
| cash per share | 11.27 |
| operating cash flow per share | 7.02 |
| free cash flow operating cash flow ratio | 0.80 |
| cash flow coverage ratios | 0.43 |
| short term coverage ratios | 10.53 |
| capital expenditure coverage ratio | 4.38 |
Frequently Asked Questions
When was the last time ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) reported earnings?
ANI Pharmaceuticals, Inc. (ANIP) published its most recent earnings results on 07-11-2025.
What is ANI Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)'s trailing twelve months ROE is -2.54%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ANI Pharmaceuticals, Inc. (ANIP) currently has a ROA of -0.82%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ANIP's net profit margin stand at?
ANIP reported a profit margin of -1.48% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ANIP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.54 in the most recent quarter. The quick ratio stood at 1.96, with a Debt/Eq ratio of 0.73.